Physician profile
Gary Baziz
NPI 1104823459
$2,678.16
in general payments reported to CMS, 2019-2025
16 companies · $521 in 2025
The $521 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $220 · 2021: $317 · 2022: $426 · 2023: $213 · 2024: $474 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $668.63 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $587.46 | 2019-2025 | Precision7, Rocklatan, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $325.44 | 2019-2021 | |
| Abbvie INC. | $300.97 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $172.34 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Coopervision INC. | $143.74 | 2019-2025 | Myday Contact Lens, Onefit Contact Lens |
| Sight Sciences, INC. | $141.41 | 2024 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $103.29 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $52.58 | 2023-2024 | Cequa |
| Oyster Point Pharma, INC. | $39.61 | 2023-2024 | Tyrvaya, Ryzumvi |
| Aerie Pharmaceuticals, INC. | $35.38 | 2021 | |
| Allergan, INC. | $31.18 | 2021-2022 | |
| Dompe US, INC. | $30.79 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Apellis Pharmaceuticals, INC. | $16.13 | 2025 | Syfovre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Baziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.